Hyperleukocytosis predicts inferior clinical outcome in pediatric acute myeloid leukemia.

Lu-Hong XuJing-Wen WangYin WangFeng-Ying Yang

Published in: Hematology (Amsterdam, Netherlands) (2021)

HL might predict inferior clinical outcome in pediatric AML. SCT is an effective therapy for AML, but it may have no better effect on the survival of patients with HL, compared to chemotherapy.

Keyphrases

acute myeloid leukemia
allogeneic hematopoietic stem cell transplantation
squamous cell carcinoma
locally advanced
young adults
acute lymphoblastic leukemia
free survival